VedolizumabLack of efficacy following off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1938卷 / 1期

关键词：

D O I：

10.1007/s40278-023-31391-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：1250 / 1250

相关论文

共 50 条

[1] Benralizumab/vedolizumabLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1959 (1) : 142 - 142
[2] Golimumab/ustekinumab/vedolizumabLack of efficacy following off-label use: 3 case reports
Reactions Weekly, 2023, 1944 (1) : 286 - 286
[3] AntibacterialsLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1920 (1) : 43 - 43
[4] DexamethasoneLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1887 (1) : 259 - 259
[5] EculizumabLack of efficacy following off-label use: case report
Reactions Weekly, 2021, 1862 (1) : 196 - 196
[6] VenetoclaxLack of efficacy following off-label use: case report
Reactions Weekly, 2025, 2041 (1) : 398 - 398
[7] DexamethasoneLack of efficacy following off-label use: case report
Reactions Weekly, 2023, 1967 (1) : 143 - 143
[8] FavipiravirLack of efficacy following off-label use: case report
Reactions Weekly, 2023, 1945 (1) : 254 - 254
[9] AmiodaroneLack of efficacy following off-label use: case report
Reactions Weekly, 2023, 1969 (1) : 29 - 29
[10] RituximabLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1905 (1) : 444 - 444

← 1 2 3 4 5 →